30 Day Trial

NuVasive Posts 4Q15/2015 Revenue

Share:

NuVasive (NUVA) posted 4Q15 revenue of US $215.3MM, +6.8% vs. 4Q14, and 2015 revenue of $811.1MM, +8.2% vs. 2014. Growth reflects constant currency. Further, NUVA has closed its acquisition of Ellipse Technologies. 

NUVA acquired Ellipse for $380MM in cash, with a potential $30MM milestone payable in 2017 pending certain revenue targets. 

Source: NuVasive, Inc.